New Drugs and Targets for Asthma & COPD
Imperial College London / National Heart & Lung Institute
Archive
25.11.2009 - 27.11.2009 London
Course Content
This popular annual course is focussed on the identification of novel targets and development of new approaches and therapies for asthma, allergy and COPD. These conditions cause a large and increasing global burden of disease. Presentations by clinical academics and senior members of the pharmaceutical industry cover the latest breakthroughs in research and clinical development of new drugs in this rapidly changing area.
This popular annual course is focussed on the identification of novel targets and development of new approaches and therapies for asthma, allergy and COPD. These conditions cause a large and increasing global burden of disease. Presentations by clinical academics and senior members of the pharmaceutical industry cover the latest breakthroughs in research and clinical development of new drugs in this rapidly changing area.
Target Audience
The course will be of particular relevance to those in the pharmaceutical industry, researchers in the field of respiratory medicine, and specialised clinicians and health care professionals
The course will be of particular relevance to those in the pharmaceutical industry, researchers in the field of respiratory medicine, and specialised clinicians and health care professionals
Enquiries and Registration:
Ms. Karina Dixon
Clinical Research, Critial Care, Internal Medicine
Languages
English
English
Fees
GBP 650,00
GBP 650,00
Organizer contact info
Dovehouse Street
SW3 6LY London
United Kingdom
Dovehouse Street
SW3 6LY London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
